The Fight to End Childhood RSV in Indian Country
This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. At first, Ethel Branch thought her two-year-old son, Patro, had a cold or maybe the flu. But on a chilly day in November 2022, a seemingly common childhood ailment took a…
